Investors focus on growth and value stocks with strong fundamentals, while cautioned against seemingly profitable companies facing challenges.
Bills RB James Cook skips practice amid contract talks, seeking a lucrative extension worth $15 million per year.
IDEXX's strong Q2 results and raised FY25 outlook highlight its innovative diagnostic products and software, driving customer loyalty and long-term growth.
Investors focus on growth and value stocks with strong fundamentals, while cautioned against seemingly profitable companies facing challenges.
Bills RB James Cook skips practice amid contract talks, seeking a lucrative extension worth $15 million per year.
IDEXX's strong Q2 results and raised FY25 outlook highlight its innovative diagnostic products and software, driving customer loyalty and long-term growth.